Healios KK Ord Shs HLOSF

Healthcare Biotechnology

HEALIOS K.K. is a Japan-based company mainly engaged in research and development of pharmaceutical products. The Company has compound pharmaceutical products line and induced pluripotent stem cell (iPSC) regenerative medicine product line. The compound pharmaceutical product line contains HLM0021, HLM0022 and HLM0023. The products are ophthalmological surgery adjuvants, mainly contain brilliant blue G-250 (BBG250) which help capsule temporarily safely stained to protect the inner limiting membranes and lens during surgery of vitreous and cataract. The iPSC regenerative medicine product line contains HLCR011 and HLCR012. The products are in the preclinical testing and preparation for trial in Japan, which are candidate of regenerative medicine products. The products are iPS cell derived retinal pigment epithelium (RPE) cell suspension and sheet developed in Japan, United States and Europe.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Next Steps

<< Previous

Bullboard Posts

Next >>

Comment by waynedon Oct 06, 2011 4:23pm

212 Views

Post# 19127283

RE: Next Steps

As bad as Halo management is , Hudbay`s is a lot worse. It is a stroke of luck that it is such a prolific company that it is able to prosper despite the best efforts of it`s management to ruin it. Remember they have been able to consistently lose money at $4 plus copper . Even now they could buy Halo with it`s own cash and still have money left over , as well as the assets right outside it`s door . Dealings with either one of these companies makes my skin crawl
Maybe the way to go is to contact Pinetree .

<< Previous

Bullboard Posts

Next >>

Silvercorp to expand into Ecuador with C$200M Adventus acquisition